ZVRA FY 2019 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$559M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M

Gross Profit

$10M77.1% margin

Operating Income

-$20M-158.4% margin

Net Income

-$25M-191.0% margin

EPS (Diluted)

$-13.23

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$11M

Total Liabilities

$85M

Stockholders' Equity

-$74M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$0	—
Gross Profit	$10M	-$324,000	+3153.7%
Operating Income	-$20M	-$56M	+63.6%
Net Income	-$25M	-$56M	+56.6%